Company profile
Zivo Bioscience, Inc. CIK 1101026
Tickers
ZIVO (OTC) · ZIVOW (OTC)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Bloomfield Hills, MI 48304
Fiscal year end
2024 (FY)
Key Financials
Revenue
$157.2K
Net income
-$13.38M
Total assets
$1.64M
Total liabilities
$2.16M
Stockholders' equity
-$514.9K
Cash & equivalents
$1.54M
Operating income
-$13.36M
Operating cash flow
-$4.31M
Capital expenditures
—
Fiscal year 2024, via 10-K filed 2025-03-18. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-8,498.9%
Net margin
-8,513.4%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
131.3%
Equity / assets
-31.3%
CapEx / revenue
—
Operating cash flow / net income
0.32×
Derived from the fiscal year 2024 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2024
$157.2K
-$13.38M
$1.64M
$2.16M
-$514.9K
2023
$27.7K
-$7.78M
$555.7K
$2.76M
-$2.21M
2022
$0
-$8.75M
$2.12M
$2.13M
-$10.6K
2021
$0
-$8.76M
$8.99M
$2.95M
$6.04M
2020
$20.0K
-$9.11M
$220.2K
$11.53M
-$11.31M
Company Details
SIC code
2836
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 4
2026-04-24
Financials filed via
Form 10-K
filed 2025-03-18
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Bloomfield Hills, MI 48304
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:35 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.